Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts. Before I hand over to AstraZeneca, I'd like to read the safe harbor statement.
A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...
First for Women on MSN2h
Ozempic Now FDA-Approved for Kidney Disease-Here's What to KnowGLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback